Cited by 143

The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.

Inactivation of the Fanconi Anemia Group C Gene Augments Interferon-γ–Induced Apoptotic Responses in Hematopoietic Cells

Rathbun, R. Keaney, Faulkner, Gregory R., Ostroski, Marika H., Christianson, Tracy A., Hughes, Grant, Jones, Gary, Cahn, Robert, Maziarz, Richard, Royle, Gordon, Keeble, Winifred, Heinrich, Michael C., Grompe, Markus, Tower, Paula A., Bagby, Grover C.·1997·Blood

Abstract

Hematopoietic progenitor cells (HPC) from mice nullizygous at the Fanconi anemia (FA) group C locus (FAC −/−) are hypersensitive to the mitotic inhibitory effects of interferon (IFN-γ). We tested the hypothesis that HPC from the bone marrow of Fanconi group C children are similarly hypersensitive and that the fas pathway is involved in affecting programmed cell death in response to low doses of IFN-γ. In normal human and murine HPC, IFN-γ primed the fas pathway and induced both fas and interferon response factor-1 (IRF-1) gene expression. These IFN-γ-induced apoptotic responses in HPC from the marrow of a child with FA of the C group (FA-C) and in FAC −/− mice occurred at significantly lower IFN doses (by an order of magnitude) than did the apoptotic responses of normal HPC. Treatment of FA-C CD34+ cells with low doses of recombinant IFN-γ, inhibited growth of colony forming unit granulocyte-macrophage and burst-forming unit erythroid, while treatment with blocking antibodies to fas augmented clonal growth and abrogated the clonal inhibitory effect of IFN-γ. Transfer of the normal FAC gene into FA-C B-cell lines prevented mitomycin C–induced apoptosis, but did not suppress fas expression or inhibit the primed fas pathway. However, the kinetics of Stat1-phosphate decay in IFN-γ–treated cells was prolonged in mutant cells and was normalized by transduction of the normal FAC gene. Therefore, the normal FAC protein serves, in part, to modulate IFN-γ signals. HPC bearing inactivating mutations of FAC fail to normally modulate IFN-γ signals and, as a result, undergo apoptosis executed through the fas pathway.

Overview

Integrity signals

Registry

Crossref · 10.1182/blood.v90.3.974

Cites

3 of 3 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 3 references

Research works printed but not linked: 63

  1. Schroeder, 1976, Formal genetics of Fanconi's anemia., Hum Genet, 32, 257, 10.1007/BF00295817 · DOI
  2. Auerbach, 1991, Leukemia and preleukemia in Fanconi anemia patients: A review of the literature and report of the International Fanconi Anemia Registry., Cancer Genet Cytogenet, 51, 1, 10.1016/0165-4608(91)90002-C · DOI
  3. Butturini, 1994, Hematologic abnormalities in Fanconi anemia: An International Fanconi Anemia Registry Study., Blood, 84, 1650, 10.1182/blood.V84.5.1650.1650 · DOI · Paper page
  4. Liu, 1994, Fanconi anemia and novel strategies for therapy., Blood, 84, 3995, 10.1182/blood.V84.12.3995.bloodjournal84123995 · DOI
  5. Auerbach, 1989, International Fanconi Anemia Registry: relation of clinical symptoms to diepoxybutane sensitivity., Blood, 73, 391, 10.1182/blood.V73.2.391.391 · DOI
  6. Auerbach, 1981, Prenatal and postnatal diagnosis and carrier detection of Fanconi anemia by a cytogenetic method., Pediatrics, 67, 128, 10.1542/peds.67.1.128 · DOI
  7. Strathdee, 1992, Evidence for at least four Fanconi anaemia genes including FACC on chromosome 9., Nat Genet, 1, 196, 10.1038/ng0692-196 · DOI
  8. Joenje, 1995, Classification of Fanconi anemia patients by complementation analysis: Evidence for a fifth genetic subtype., Blood, 86, 2156, 10.1182/blood.V86.6.2156.bloodjournal8662156 · DOI
  9. Lo, 1996, Expression cloning of a cDNA for the major Fanconi anaemia gene, FAA., Nat Genet, 14, 320, 10.1038/ng1196-320 · DOI
  10. Fanconi anaemia/breast cancer consortium, 1996, Positional cloning of the Fanconi anaemia group A gene., Nat Genet, 14, 324, 10.1038/ng1196-324 · DOI
  11. Gibson, 1994, Genetic mapping of the FACC gene and linkage analysis in Fanconi anaemia families., J Med Genet, 31, 868, 10.1136/jmg.31.11.868 · DOI
  12. Whitney, 1995, Microcell mediated chromosome transfer maps the Fanconi anaemia group D gene to chromosome 3p., Nat Genet, 11, 341, 10.1038/ng1195-341 · DOI
  13. Pronk, 1995, Localisation of the Fanconi anaemia complementation group A gene to chromosome 16q24.3., Nat Genet, 11, 338, 10.1038/ng1195-338 · DOI
  14. Strathdee, 1992, Cloning of cDNAs for Fanconi's anaemia by functional complementation., Nature, 356, 763, 10.1038/356763a0 · DOI
  15. Strathdee, 1992, Erratum: Cloning of cDNAs for Fanconi's anaemia by functional complementation., Nature, 358, 434, 10.1038/358434a0 · DOI
  16. Wevrick, 1993, Cloning and analysis of the murine Fanconi anemia group C cDNA., Hum Mol Genet, 2, 655, 10.1093/hmg/2.6.655 · DOI
  17. Youssoufian, 1994, Localization of Fanconi anemia C protein to the cytoplasm of mammalian cells., Proc Natl Acad Sci USA, 91, 7975, 10.1073/pnas.91.17.7975 · DOI
  18. Yamashita, 1994, The Fanconi anemia polypeptide FACC is localized to the cytoplasm., Proc Natl Acad Sci USA, 91, 6712, 10.1073/pnas.91.14.6712 · DOI
  19. Youssoufian, 1996, Cytoplasmic localization of FAC is essential for the correction of a pre-repair defect in Fanconi anemia group C cells., J Clin Invest, 97, 2003, 10.1172/JCI118635 · DOI
  20. Segal, 1994, Repression of Fanconi anemia gene (FACC) expression inhibits growth of hematopoietic progenitor cells., J Clin Invest, 94, 846, 10.1172/JCI117405 · DOI
  21. Walsh, 1994, A functionally active retrovirus vector for gene therapy in Fanconi anemia group C., Blood, 84, 453, 10.1182/blood.V84.2.453.453 · DOI
  22. Whitney, 1996, Germ cell defects and hematopoietic hypersensitivity to γ-interferon in mice with a targeted disruption of the Fanconi anemia C gene., Blood, 88, 49, 10.1182/blood.V88.1.49.49 · DOI · Paper page
  23. Broxmeyer, 1986, The suppressive influences of human tumor necrosis factors on bone marrow hematopoietic progenitor cells from normal donors and patients with leukemia: Synergism of tumor necrosis factor and interferon gamma., J Immunol, 136, 4487, 10.4049/jimmunol.136.12.4487 · DOI
  24. Broxmeyer, 1983, Comparative analysis of the influences human gamma, alpha and beta interferons on human multipotential (CFU-GEMM), erythroid (BFU-E) and granulocyte-macrophage (CFU-GM) progenitor cells., J Immunol, 131, 1300, 10.4049/jimmunol.131.3.1300 · DOI
  25. Raefsky, 1985, Studies of interferon as a regulator of hematopoietic cell proliferation., J Immunol, 135, 2507, 10.4049/jimmunol.135.4.2507 · DOI
  26. Viale, 1991, Analysis at the clonal level of T-cell phenotype and functions in severe aplastic anemia patients., Blood, 78, 1268, 10.1182/blood.V78.5.1268.1268 · DOI
  27. Nakao, 1992, Interferon-gamma gene expression in unstimulated bone marrow mononuclear cells predicts a good response to cyclosporine therapy in aplastic anemia., Blood, 79, 2532, 10.1182/blood.V79.10.2532.bloodjournal79102532 · DOI
  28. Nistico, 1994, Gamma-Interferon gene expression in the bone marrow of patients with aplastic anemia., Ann Intern Med, 120, 463, 10.7326/0003-4819-120-6-199403150-00003 · DOI · Paper page
  29. Maciejewski, 1994, Bone marrow and peripheral blood lymphocyte phenotype in patients with bone marrow failure., Exp Hematol, 22, 1102
  30. Selleri, 1996, Interferon-gamma constitutively expressed in the stromal microenvironment of human marrow cultures mediates potent hematopoietic inhibition., Blood, 87, 4149, 10.1182/blood.V87.10.4149.bloodjournal87104149 · DOI · Paper page
  31. Selleri, 1995, Interferon-gamma and tumor necrosis factor-α suppress both early and late stages of hematopoiesis and induce programmed cell death., J Cell Physiol, 165, 538, 10.1002/jcp.1041650312 · DOI
  32. Nagafuji, 1995, Functional expression of Fas antigen (CD95) on hematopoietic progenitor cells., Blood, 86, 883, 10.1182/blood.V86.3.883.883 · DOI
  33. Maciejewski, 1995, Fas antigen expression on CD34+ human marrow cells is induced by interferon gamma and tumor necrosis factor alpha and potentiates cytokine-mediated hematopoietic suppression in vitro., Blood, 85, 3183, 10.1182/blood.V85.11.3183.bloodjournal85113183 · DOI
  34. Oehm, 1992, Purification and molecular cloning of the APO-1 cell surface antigen, a member of the tumor necrosis factor/nerve growth factor receptor superfamily. Sequence identity with the Fas antigen., J Biol Chem, 267, 10709, 10.1016/S0021-9258(19)50076-X · DOI
  35. Smith, 1994, The TNF receptor superfamily of cellular and viral proteins: Activation, costimulation, and death., Cell, 76, 959, 10.1016/0092-8674(94)90372-7 · DOI
  36. Suda, 1993, Molecular cloning and expression of the Fas ligand, a novel member of the tumor necrosis factor family., Cell, 75, 1169, 10.1016/0092-8674(93)90326-L · DOI
  37. Ju, 1995, Fas(CD95)/FasL interactions required for programmed cell death after T-cell activation [see comments]., Nature, 373, 444, 10.1038/373444a0 · DOI
  38. Yonehara, 1989, A cell-killing monoclonal antibody (anti-Fas) to a cell surface antigen co-downregulated with the receptor of tumor necrosis factor., J Exp Med, 169, 1747, 10.1084/jem.169.5.1747 · DOI
  39. Itoh, 1991, The polypeptide encoded by the cDNA for human cell surface antigen Fas can mediate apoptosis., Cell, 66, 233, 10.1016/0092-8674(91)90614-5 · DOI
  40. Owen-Schaub, 1992, DNA fragmentation and cell death is selectively triggered in activated human lymphocytes by Fas antigen engagement., Cell Immunol, 140, 197, 10.1016/0008-8749(92)90187-T · DOI
  41. Chinnaiyan, 1995, FADD, a novel death domain-containing protein, interacts with the death domain of Fas and initiates apoptosis., Cell, 81, 505, 10.1016/0092-8674(95)90071-3 · DOI · Paper page
  42. Chinnaiyan, 1996, FADD/MORT1 is a common mediator of CD95 (Fas/APO-1) and tumor cell necrosis factor receptor-induced apoptosis., J Biol Chem, 271, 4961, 10.1074/jbc.271.9.4961 · DOI
  43. Muzio, 1996, FLICE, a novel FADD-homologous ICE/CED-3-like protease, is recruited to the CD95 (Fas/APO-1) death — inducing signaling complex., Cell, 85, 817, 10.1016/S0092-8674(00)81266-0 · DOI · Paper page
  44. Alnemri, 1996, Human ICE/CED-3 protease nomenclature., Cell, 87, 171, 10.1016/S0092-8674(00)81334-3 · DOI
  45. Tewari, 1995, Fas- and tumor necrosis factor-induced apoptosis is inhibited by the poxvirus crmA gene product., J Biol Chem, 270, 3255, 10.1074/jbc.270.7.3255 · DOI
  46. Enari, 1996, Sequential activation of ICE-like and PCC32-like proteases during Fas-mediated apoptosis., Nature, 380, 723, 10.1038/380723a0 · DOI
  47. Maciejewski, 1995, Increased expression of Fas antigen on bone marrow CD34+ cells of patients with aplastic anaemia., Br J Haematol, 91, 245, 10.1111/j.1365-2141.1995.tb05277.x · DOI
  48. Miller, 1989, Improved retroviral vectors for gene transfer and expression., BioTechniques, 7, 980
  49. Kozak, 1990, Ping-pong amplification of a retroviral vector achieves high-level gene expression: Human growth hormone production., J Virol, 64, 3500, 10.1128/JVI.64.7.3500-3508.1990 · DOI
  50. Segal, 1992, Specific repression of granulocyte-macrophage and granulocyte colony-stimulating factor gene expression in interleukin-1-stimulated endothelial cells with antisense oligodeoxynucleotides., Blood, 80, 609, 10.1182/blood.V80.3.609.609 · DOI
  51. Towbin, 1979, Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: Procedure and some applications., Proc Natl Acad Sci USA, 76, 4350, 10.1073/pnas.76.9.4350 · DOI
  52. Koopman, 1994, Annexin V for flow cytometric detection of phosphatidylserine expression on B cells undergoing apoptosis., Blood, 84, 1415, 10.1182/blood.V84.5.1415.bloodjournal8451415 · DOI
  53. Andree, 1990, Binding of vascular anticoagulant alpha (VAC alpha) to planar phospholipid bilayers., J Biol Chem, 265, 4923, 10.1016/S0021-9258(19)34062-1 · DOI
  54. Gavrieli, 1992, Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation., J Cell Biol, 119, 493, 10.1083/jcb.119.3.493 · DOI · Paper page
  55. Martin, 1996, Phosphatidylserine externalization during CD95-induced apoptosis of cells and cytoplasts requires ICE/CED-3 protease activity., J Biol Chem, 271, 28753, 10.1074/jbc.271.46.28753 · DOI
  56. Barcena, 1996, Expression of Fas/CD95 and Bcl-2 by primitive hematopoietic progenitors freshly isolated from human fetal liver., Blood, 88, 2013, 10.1182/blood.V88.6.2013.bloodjournal8862013 · DOI
  57. Shual, 1993, Polypeptide signalling to the nucleus through tyrosine phosphorylation of Jak and Stat proteins., Nature, 366, 580, 10.1038/366580a0 · DOI
  58. Darnell, 1994, Jak-STAT pathways and transcriptional activation in response to IFNs and other extracellular signaling proteins., Science, 264, 1415, 10.1126/science.8197455 · DOI · Paper page
  59. Kim, 1996, Regulation of interferon-γ-activated STAT1 by the ubiquitin-proteasome pathway., Science, 273, 1717, 10.1126/science.273.5282.1717 · DOI
  60. Scuderi, 1987, Recombinant interferon-gamma stimulates the production of human tumor necrosis factor in vitro., J Interferon Res, 7, 155, 10.1089/jir.1987.7.155 · DOI
  61. Schultz, 1993, Tumor necrosis factor-alpha overproduction in Fanconi's anemia., Am J Hematol, 42, 196, 10.1002/ajh.2830420211 · DOI
  62. Alter, 1996, Fanconi's anemia and malignancies., Am J Hematol, 53, 99, 10.1002/(SICI)1096-8652(199610)53:2<99::AID-AJH7>3.0.CO;2-Z · DOI
  63. Alter, 1992, Leukemia and preleukemia in Fanconi's anemia., Cancer Genet Cytogenet, 58, 206, 10.1016/0165-4608(92)90116-P · DOI

Cited by

Metadata

Authors
Rathbun, R. K., Faulkner, G. R., Ostroski, M. H., Christianson, T. A., Hughes, G., Jones, G., Cahn, R., Maziarz, R., Royle, G., Keeble, W., Heinrich, M. C., Grompe, M., Tower, P. A., & Bagby, G. C.
Affiliations
From the Division of Hematology and Medical Oncology, Oregon Health Sciences University, Portland; and the Molecular Hematopoiesis Laboratory, VA Medical Center, Portland, OR.
Venue
Blood
Published
1997-08-01
Volume
90
Issue
3
Pages
974-985
ISSN
  • 1528-0020
  • 0006-4971
Cited by
143
References
3
Language
en

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review